Evidence map›Paper›PMID 32670820›Full record

ReviewJournal of traditional and complementary medicine2020

Inositols and metabolic disorders: From farm to bedside.

M Caputo, E Bona, I Leone, M T Samà, A Nuzzo, A Ferrero, G Aimaretti, P Marzullo, F Prodam

2 registry-linked trialsOpen access · diamondAbstract readReview
In one paragraph

Review in Journal of traditional and complementary medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05234203 nacompletednot on this mapstarted 2022, after this paper: background citation

The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age

TypeinterventionalSponsorBig Bold Health, PBCRan2022 to 2022Enrolled50ConditionsImmunity Disorders, Aging, InflammationArmsHTB Rejuvenate
NCT07256769 recruitingnot on this mapstarted 2025, after this paper: background citation

Synergic Role of Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis in Breast Cancer Patients Treated With Aromatase Inhibitors

TypeobservationalSponsorRegina Elena Cancer InstituteRan2025 to 2028Enrolled134ConditionsOsteoporosis Secondary, Breast Cancer FemalesArmsGroup 1: calcium carbonate/cholecalciferol, Group 2: Synostea® (calcium carbonate/cholecalciferol/vitamin K/α-lactalbumin/ d-chiro-inositol)
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Frontiers in endocrinology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

M CaputoEndocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
E BonaDepartment of Sciences and Technological Innovation, University of Piemonte Orientale, Alessandria, Italy.
I LeoneEndocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
M T SamàEndocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
A NuzzoEndocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
A FerreroEndocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
G AimarettiEndocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
P MarzulloEndocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
F ProdamEndocrinology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITOspedale San Giuseppe · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inositol and its derivates are catching interest in metabolism since taking part in several physiological processes, including endocrine modulation. Through several mechanisms mostly mediated by insulin signaling, these compounds regulate the activities of several hormones and are essential in oocytes maturation. It is interesting to point out the contribution of an inositol deficiency in the development of several diseases, mainly in the metabolic and endocrine setting. Inositols derive from both diet and endogenous production; among causes of inositol deficiency reduced dietary intake, increased catabolism and/or excretion, decreased biosynthesis, inhibition of gut and cellular uptake and altered microbiota could be considered. Mounting direct and indirect evidence suggests that the two main isoforms (Myo-inositol-inositol, D-chiro-inositol) are implied in glycemic and lipidic metabolism and supplementation yield a beneficial effect on these parameters without hazards for health. Moreover, they have a role in polycystic ovary syndrome, acting as insulin-sensitizing agents and free radical scavengers, helping to regulate metabolism and promoting ovulation. The aim of this narrative review is to discuss the role of inositols in metabolic function disorders paying attention to whether these compounds could be efficacious and safe as a therapeutic agent with a focus on dietary intake and the role of gut microbiota.

Indexed as

DietFood supplementInositolLipidsMetabolismMicrobiotaOvaryType 2 diabetes

Identifiers

PMID32670820
PMCPMC7340869
OpenAlexW3013141036

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.